Register
  • Community
    • Physicians
    • Editors
    • Experts
    • Code of conduct
    • Blog
    • Terms of Use
    • Privacy Policy
    • Sitemap
  • Company
    • About
    • Publications
    • Press
    • Careers
  • Programs
    • Journal Club
    • Targeted Topic
    • Clinical Trial
    • Tumor Board
  • Contact Us
  • Sign in

Neurology

COVID-19   

Questions discussed in this category


What is your preferred first line treatment for chronic fatigue in patients with long Covid?
2 Answers available

How do you approach the timing of COVID-19 vaccination for patients with multiple sclerosis on B-cell depleting therapies?
3 Answers available
130049985


Papers discussed in this category


Neurology, 2020 Jul 29
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.

Cells, 2018 Dec 28
Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.

Related Topics in Neurology

  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Cancers
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Non-malignant Disease
  • Pediatric Oncology

Copyright © 2023 theMednet
All Rights Reserved.